A Multiple Ascending Dose Study with AZD9164 given for 13 days in Healthy Male and Female Subjects and in Patients with Chronic Obstructive Pulmonary Disease

Study identifier:D1882C00002

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Terminated/Withdrawn

Official Title

A Phase I, Multi centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD9164 given once daily as Inhaled Formulation via Turbuhaler for 13 days in Healthy Male and Female Subjects and in Patients with Chronic Obstructive Pulmonary Disease (COPD)

Medical condition

Healthy, COPD

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD9164 Turbuhaler®, Placebo Turbuhaler®

Sex

All

Actual Enrollment

36

Study type

Interventional

Age

18 Years +

Date

Study Start Date: 01 Dec 2009
Primary Completion Date: 01 Jun 2010
Study Completion Date: 01 Jun 2010

Study design

Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Basic Science

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria